Abstract:As rate-limited enzyme of polyol pathway, aldose reductase (ALR2) is one of the key inhibitory targets for alleviating diabetic complications. To reduce the toxic side effects of the inhibitors and to decrease the level of oxidative stress, the inhibitory selectivity towards ALR2 against detoxicating aldehyde reductase (ALR1) and antioxidant activity are included in the design of multifunctional ALR2 inhibitors. Hydroxypyridinone derivatives were designed, synthesized and evaluated their inhibitory behavior and antioxidant activity. Notably, {2-[2-(3,4-dihydroxy-phenyl)-vinyl]-5-hydroxy-4-oxo-4H-pyridin-1-yl}-acetic acid (7l) was the most potent, with IC50 values of 0.789 μM. Moreover, 7l showed excellent selectivity towards ALR2 with selectivity index 25.23, which was much higher than that of eparlestat (17.37), the positive control. More significantly, 7l performed powerful antioxidative action. At a concentration of 1 μM, phenolic compounds 7l scavenged DPPH radical with an inhibitory rate of 41.48%, which was much higher than that of the well-known antioxidant Trolox, at 11.89%. Besides, 7l remarkably suppressed lipid peroxidation with a rate of 88.76% at a concentration of 100 μM. The binding mode derived from molecular docking proved that the derivatives were tightly bound to the activate site, suggesting strongly inhibitory action of derivatives against ALR2. Therefore, these results provided an achievement of multifunctional ALR2 inhibitors capable with potency for both selective ALR2 inhibition and as antioxidants.

Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity

A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity.

Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.

Multifunctional aldose reductase inhibitors based on 2H-benzothiazine 1,1-dioxide

Synthesis and structure–activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity

Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1 H )-one as potent aldose reductase inhibitors with antioxidant activity

Synthesis of Benzothiadiazine Derivatives Exhibiting Dual Activity As Aldose Reductase Inhibitors and Antioxidant Agents

(5-Hydroxy-4-oxo-2-styryl-4H-pyridin-1-yl)-acetic Acid Derivatives as Multifunctional Aldose Reductase Inhibitors

1,2-Benzothiazine 1,1-Dioxide Carboxylate Derivatives As Novel Potent Inhibitors of Aldose Reductase

Pyridothiadiazine Derivatives As Aldose Reductase Inhibitors Having Antioxidant Activity.

Design of Benzothiazolone‐Based Carboxylic Acid Aldose Reductase Inhibitors

Identification of Quinoxalin-2(1H)-one Derivatives As a Novel Class of Multifunctional Aldose Reductase Inhibitors

An efficient synthesis of quinoxalinone derivatives as potent inhibitors of aldose reductase.

An Efficient Synthesis of Quinoxalinone Derivatives As Potent Inhibitors of Aldose Reductase

Acetic Acid Derivatives of 3,4-Dihydro-2h-1,2,4-benzothiadiazine 1,1-Dioxide As a Novel Class of Potent Aldose Reductase Inhibitors.

Designing of Acyl Sulphonamide Based Quinoxalinones As Multifunctional Aldose Reductase Inhibitors.

Synthesis and Structure-Activity Relationship Studies of Quinoxaline Derivatives as Aldose Reductase Inhibitors

Isatin Derivatives As a New Class of Aldose Reductase Inhibitors with Antioxidant Activity

Structure-Activity Relationships Studies of Quinoxalinone Derivatives As Aldose Reductase Inhibitors

Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.

Novel Hydroxychalcone-Based Dual Inhibitors of Aldose Reductase and Α-Glucosidase As Potential Therapeutic Agents Against Diabetes Mellitus and Its Complications.